Business
ASX falls; Mesoblast plunges 36pc; QBE, Genworth smashed – afr.com
The sharemarket is lower as banks retreat, but on track for a seventh week of gains. Mesoblast slumps as drug trial disappoints. QBE warns of $1.5 billion loss….
The Australian sharemarket has opened weaker as banks retreat and QBE Insurance tumbles after warnings of a $1.5 billion loss.
The S&P/ASX 200 is down 20.2 points, or 0.3 per cent, to 6736.5 points.
Travel stocks are under pressure as the spike in NSW COVID-19 cases has thrown Christmas travel plans into disarray with states such as Western Australia reimposing 14-days quarantine for visitors from NSW.
Qantas is down 2.8 per cent, Flight Centre has slipped 2.5 per cent and Webjet has tumbled 4.1…
-
Business14 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business16 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General13 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips